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Novel Rbfox2 isoforms associated 
with alternative exon usage in rat 
cortex and suprachiasmatic nucleus
L. M. M. Partridge & D. A. Carter
Transcriptome diversity in adult neurons is partly mediated by RNA binding proteins (RBPs), 
including the RBFOX factors. RBFOX3/NeuN, a neuronal maturity marker, is strangely depleted in 
suprachiasmatic nucleus (SCN) neurons, and may be compensated by a change in Rbfox2 expression. 
In this study, we found no superficial changes in Rbfox2 expression in the SCN, but mRNA population 
analysis revealed a distinct SCN transcript profile that includes multiple novel Rbfox2 isoforms. Of 
eleven isoforms in SCN and cerebral cortex that exhibit exon variation across two protein domains, we 
found a 3-fold higher abundance of a novel (‘−12–40’) C-terminal domain (CTD)-variant in the SCN. This 
isoform embraces an alternative reading frame that imparts a 50% change in CTD protein sequence, 
and functional impairment of exon 7 exclusion activity in a RBFOX2-target, the L-type calcium channel 
gene, Cacna1c. We have also demonstrated functional correlates in SCN gene transcripts; inclusion 
of Cacna1c exon 7, and also exclusion of both NMDA receptor gene Grin1 exon 4, and Enah exon 12, 
all consistent with a change in SCN RBFOX activity. The demonstrated regional diversity of Rbfox2 in 
adult brain highlights the functional adaptability of this RBP, enabling neuronal specialization, and 
potentially responding to disease-related neuronal dysfunction.
Alternative gene splicing is a major determinant of neuron-specific function1, affecting both individual proteins, 
and ultimately, protein interaction networks2. Multiple factors contribute to alternative splicing, and of these, 
RNA binding proteins (RBPs) are known to be important determinants of cell-specific splicing3. In neurons, 
one family of RBPs, the RNA-binding FOX homolog (RBFOX) proteins4, exert widespread effects on neuronal 
gene splicing5–7. However, the functional repertoire of RBFOX proteins remains undefined, partly because the 
three proteins in this family, RBFOX1 (A2BP1), RBFOX2 (Rbm9) and RBFOX3 (NeuN) appear to have both 
common and distinct properties4, 8. Rbfox genes are differentially expressed; Rbfox1 in neurons, heart and mus-
cle, Rbfox2 more widely in neurons, muscle and multiple progenitor cells, whereas Rbfox3/NeuN is famously 
neuron-specific4. In the adult brain, all three RBFOX proteins are widely, but again, differentially expressed across 
different regions9. RBFOX proteins share a consensus RNA binding sequence (U)GCAUG that interacts with a 
conserved RNA recognition motif (RRM) within a central region of all RBFOX proteins. Position-dependent 
binding of RBFOX proteins relative to alternative exons can mediate either exon inclusion (downstream intronic 
binding), or exon skipping (upstream intronic binding)7, 10. N-terminal (NTD) and C-terminal (CTD) domains 
of the RBFOX proteins are important additional determinants of cell-specific function11–13.
Our work demonstrating an absence of the ‘pan-neuronal’ RBP, RBFOX3/NeuN, from the majority of SCN 
neurons14 is indicative of significant changes in splicing regulation within this hypothalamic population that may 
underlie specific functional requirements of this integrative centre in the brain15. Previous studies have provided 
evidence of SCN-selective gene splicing16–18, but the mechanistic basis of these differences is unknown. In the 
current study, we have now addressed one aspect of splicing regulation in this brain region by analysing SCN 
expression and activity of the Rbfox3/NeuN sister gene, Rbfox2.
Rbfox2 was selected for this study because the RBFOX3/NeuN-negative14, SOX2-positive19 phenotype of 
SCN neurons is consistent with relative neuronal immaturity. Rbfox2 is a good candidate because unlike the 
other Rbfox genes, it is expressed early in neuronal development, and in particular, is found in early post-mitotic 
neurons in addition to mature neurons9, 20–22. Also, recent studies have shown that cortical Rbfox2 expression 
decreases in the adult brain (in general), whereas Rbfox1 has the opposite temporal profile23. Therefore, Rbfox2 
appears a likely candidate for possible expression in ‘immature’, RBFOX3-depleted, adult SCN neurons. Currently, 
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Rbfox2 is known to have a specific role in cerebellar development24, but roles of Rbfox2 in the adult brain are 
undefined.
Results
RT-PCR identification of rat brain Rbfox2 cDNA. In the absence of published sequence information 
on rat brain Rbfox2 transcripts, PCR primers (Table S1) were based on (i) a partially annotated rat transcript 
(NM_001079895.1), and (ii) rat genome sequence corresponding to mouse transcripts that have an alternative 
translation start site (eg. NM_001286418). The primer pairs used for this analysis thereby target the two alterna-
tive ATG codons recognized in mouse and human Rbfox2 transcripts11, together with a full-length open reading 
frame with known (alternative) N-terminal, RRM, and C-terminal domains (Fig. 1). However, potential alter-
native 5′ and 3′ UTR sequence is not addressed using this primer design. RT-PCR analysis revealed two distinct 
Rbfox2 transcripts in rat cerebral cortex but a very marked, and consistent, abundance of the ‘MEKK’ start tran-
script compared with the ‘MAEG’ transcript (Fig. 1A). This result was essentially identical in rat SCN (Fig. S1) 
and, superficially, levels of MEKK-containing transcripts were similar in SCN and cortex (Fig. 1A). Given these 
Figure 1. Rbfox2 is highly expressed in rat brain, and multiple isoforms are derived from a multi-exon 
transcript that includes a ‘MEKK’ ATG start. (A) Representative agarose gel electrophoresis images of RT-PCR 
analysis using forward primers directed against two different Rbfox2 start sites represented as ‘MEKK’ and 
‘MAEG’. Left: abundance of ‘MEKK’ isoforms compared with ‘MAEG’ isoforms in rat cerebral cortex (COR). 
Centre: similar abundance of ‘MEKK’ isoforms in cortex and suprachiasmatic nucleus (SCN). Right: abundance 
of ‘MEKK’ isoforms in PC12 cells. PCR product size is estimated against either Hyperladder I (left and centre) 
or Promega 1 kb ladder (right). (B) Schematic representation of cloned rat brain Rbfox2 cDNA structure 
showing (predicted) alternative 5′ exons and approximate coding positions of the protein domains encoded by 
‘MEKK’ isoforms (N-terminal, NTD; RNA recognition motif domain, RRM; C-terminal, CTD). The ‘MAEG’ 
‘exon’ (E) is shown dashed to indicate that there may be more than 1 exon in this alternative 5′ start. Exons 
and introns are not to scale. (C) Schematic representation of rat brain Rbfox2 cDNA structure showing sites of 
exon variation (dashed boxes), and alternative exon insertions (bold italic numbers) in cloned rat brain Rbfox2 
cDNAs. Arrows indicate the location of proximal intronic (within 500 nt) UGCAUG (consensus RBFOX-
binding) sequences.
www.nature.com/scientificreports/
3SCientifiC REPORTS | 7: 9929  | DOI:10.1038/s41598-017-10535-3
results, subsequent experiments were focused on MEKK-containing transcripts/protein (see protein data below), 
but it is recognized that these RT-PCR analyses do not exclude the expression of alternative transcripts. Initial 
sequence analysis of the RT-PCR-generated rat cortex MEKK transcript revealed a 1175 bp sequence that includes 
some 5′ and 3′ UTR sequence included in primers RBFF6 and RBFR3 (Supplemental data, SI1). Mapping this 
sequence to the rat genome with BLAT indicates division into 13 exons. The open reading frame (ORF) sequence 
of 1143 bp codes for a 381 amino acid protein that is homologous to, and highly conserved with, annotated mouse 
(NP_001104298.1; 99.7% identity) and human (NP_001336926.1; 98.7% identity) RBFOX2 isoforms. Of note, the 
predicted CTD is 100% conserved across these 3 species.
RBFOX2 has abundant nuclear expression in SCN. Given the identification of ‘MEKK’-containing 
Rbfox2 transcripts in rat cortex and SCN, we next used an antibody directed against this N-terminal epitope to 
analyse RBFOX2 protein expression in adult rat brain (Fig. 2). This analysis revealed abundant (MEKK) RBFOX2 
protein in rat brain, including cortex (Figs 2 and S2), and also showed that this isoform ‘family’ (see results 
below) is similarly abundant in the SCN, a region where the related NeuN/RBFOX3 protein is unusually sparse 
(Fig. 2A–C). Microscopic inspection of RBFOX2 immunoreactivity within individual cells of the SCN did not 
reveal any distinction in RBFOX2 levels between NeuN-ve and the rare NeuN + ve cells (Fig. S2), and RBFOX2 
was broadly expressed across the SCN with no apparent localization to sub-region (Fig. 2B). Further inspection 
of RBFOX2 immunoreactivity indicated an exclusively nuclear distribution in the adult rat brain regions analysed 
here (Fig. 2D–F). Expression of RBFOX2 in the nuclear region of neurons was confirmed by co-localization 
with MeCP2 (Fig. S3). In order to extend our understanding of the distribution of RBFOX protein in rat brain, 
further analysis of neonatal rat brain (Fig. 2G–I) revealed some neurons with distinctive RBFOX2 localization in 
extra-nuclear regions of the cells.
Distinct populations of Rbfox2 isoforms in the SCN and cortex. Following the initial identification 
of MEKK-containing transcripts in adult rat cortex (above), we cloned and sequenced a similar PCR product 
from adult rat SCN and were surprised to find a sequence with two internal variations (12 bp deletion at the 
start of exon 9, and a 40 bp full deletion of exon 10; a variant termed −12–40; Supplemental data SI1 and 2). 
Attempts to confirm this result revealed additional sequence variation, and so we undertook a systematic analysis 
of both cortex and SCN transcript sequences from multiple independent samples of rat brain (Table 1). This anal-
ysis revealed a diversity of transcripts in both brain regions, but at the same time, a clear distinction in isoform 
populations.
In this sequence analysis of 44 clones (22 SCN, 22 cortex; each from 3 independent samples), a total of 6 loci 
of variation across the Rbfox2 ORF were identified (Supplemental data SI1 and 2), with multiple different events 
at some of these sites, giving rise to a total of 11 distinct isoforms, including the ‘non-variant’ sequence identified 
above (Fig. 1C; Table 1, Supplemental data, SI1 and SI2). All of these isoforms are novel in this biological context, 
and therefore this study provides the first experimental evidence for the expression of these isoforms. It should be 
noted, however, that many of these isoforms are Gnomon-predicted from ab initio modelling (Table 1; www.ncbi.
nlm.nih.gov/genome/annotation_euk/gnomon), and some involve documented alternatively spliced exons (see 
Discussion). ORF analysis indicates a direct correspondence between isoform sequence and our detected brain 
protein expression because all of the cloned isoforms maintain the N-terminal region recognized by the antibody 
used in the immunohistochemical analysis. Furthermore, our demonstration of (primarily) nuclear RBFOX2 in 
adult brain indicates the presence of functional nuclear localization signals (NLS) within the complement of dif-
ferent isoforms, and this appears to hold because, although many of the isoforms lack the known C-terminal NLS13 
and the recently identified N-terminal NLS13 a conserved NLS (KSTPKRLHVSNIPFRFRDPDLRQMFGQFGKI) 
is identified in the majority of isoforms using the CNLA Mapper software. Remarkably, given the nature of the 
relatively short sequence insertions and deletions found here, only one of the sequenced variants is associated 
with premature termination of the ORF, and likely targeting for nonsense-mediated decay (NMD). This is the 
−93/+73 isoform, identical to a mouse isoform identified by Dredge & Jensen25 as targeted for NMD due to a 
nonsense codon more than 50–55 bp upstream of an exon-exon junction. All other isoforms exhibit maintenance 
of a similarly sized ORF, terminating in either ‘FAPY’ or ‘TEVT’. This organization is dependent upon the use of 
different (alternative frame) termination codons that are spaced 7 bp apart at the 3′ end of the coding sequence.
Clearly, the pattern of differential isoform expression between SCN and cortex is complex and does not have 
an overt functional distinction, particularly given that the functional activities of each isoform have not been 
experimentally defined. However, our data reveal a 3-fold higher abundance of the −12–40 isoform in SCN 
compared with cortex (Table 1), and this isoform also represents >50% of the SCN isoforms. The −12 bp deletion 
results in a loss of the amino acid sequence SLPLV from the N-terminal region of the CTD, and the −40 dele-
tion results in an almost complete loss of sequence identity from VYQD in the CTD until the end of the coding 
sequence (Supplemental data, SI4 and SI5). Given the differential expression of this isoform, we therefore selected 
the −12–40 isoform for functional analysis (see below; Genbank accession number: MF177287).
RBFOX2 target sequences rat brain isoforms. Although multiple factors contribute to differential splic-
ing of neuronal genes4, RBFOX protein auto-regulation may be involved, and therefore an analysis of rat genomic 
sequence at the Rbfox2 locus was conducted in order to identify patterns of RBFOX binding sites ([U]GCAUG) 
that would be consistent with auto-regulation. This analysis (see Fig. 1C) provided evidence for Rbfox-mediated 
regulation of Rbfox2 isoform generation. Of note, there are consensus sites proximal to exon 10 and the alterna-
tive exon 10 which would be consistent with exon exclusion and inclusion respectively, and also proximal sites 
around the alternatively utilized exon 5. In other cases, such as the 12 bp loss from exon 9, no consensus sites are 
found, indicating alternative mechanisms of sequence variation in Rbfox2 isoforms.
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Figure 2. RBFOX2 is extensively expressed in rat suprachiasmatic nucleus (SCN). Representative fluorescence 
microscopic images of male PN50 and PN10 brain showing the distribution of RBFOX2 immunoreactivity in 
neurons. (A–C) Scarce and low-level expression of NeuN/RBFOX3 contrasted with abundant expression of 
RBFOX2 within the PN50 SCN (dashed line indicates the approximate confines of this brain region). Note the 
similar levels of RBFOX2 immunoreactivity in SCN and extra-SCN regions. (D–F) RBFOX2 is restricted to the 
nucleus of PN50 SCN neurons as indicated by co-localization with DAPI staining (Note invariant purple colour 
of co-localized cells imaged in (F)). (G–I) RBFOX2 is primarily restricted to the nucleus of PN10 hypothalamic 
neurons, but is also observed in the cytoplasm of isolated neurons. Arrowheads indicate two neurons exhibiting 
cytoplasmic expression of RBFOX2 (Note maintenance of red fluorescence when merged with DAPI image). 
Abbreviations: 3 V, third ventricle; DAPI, 4′,6-diamidino-2-phenylindole; NeuN, neuronal nuclei antigen/
RBFOX3. Scale bars: A-C = 100 µm; D-F = 50 µm; G-I = 20 µm.
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RBFOX splicing targets in SCN genes. Previous studies of RBFOX protein function have identified mul-
tiple exons that are included/excluded from target gene transcripts through RBFOX-dependent mechanisms (see 
Discussion). In order to investigate comparative RBFOX activity in the SCN, four of these exon targets were ana-
lysed using RT-PCR to provide a comparison of exon inclusion/exclusion in the SCN and cortex (Figs 3A and B; S4). 
Initially, we analysed exon 4 (Transcript: ENSRNOT00000037725.5), of the NMDA receptor gene, Grin1, which 
in addition to being a known RBFOX target exon9, 23 [termed exon 59], is also known to be differentially regu-
lated in SCN (exon excluded) compared with cortex (exon included)16, 17. Consequently, our demonstration that 
this exon is excluded from SCN (but not cortex) transcripts in our samples (Fig. 3A), is not only indicative of a 
region-specific difference in RBFOX activity, but also serves to confirm SCN sample integrity, given the previous 
in situ hybridization data for SCN expression16, 17.
We have also demonstrated brain region-specific regulation in two other genes that contain known RBFOX 
target exons, but which have not previously been analysed in the SCN (Fig. 3A). First, Enah (aka Mena) exon 
12 (Transcript: ENSRNOT 00000085188.1), which has a lower expression in the SCN, consistent with a loss of 
RBFOX activity7, 26. Second, Cacna1c (aka Cav1.2) exon 7 (Transcript: ENSRNOT00000052017.6) that is clearly 
expressed in SCN, but only minimally in cortex (Fig. 3), again, consistent with a loss of RBFOX activity10 (termed 
exon 9*). A quantitative analysis of Cacna1c exon 7 inclusion revealed a significantly higher level of exon 7 
included transcripts in SCN when expressed as a percentage of total PCR product (SCN: 7.0 ± 0.4%, Cortex: 
1.7 ± 0.4%; p < 0.05, Independent Student’s t test, n = 3/group, values are Mean ± SEM). In contrast, Cacna1c 
exon 29 inclusion is complete in both SCN and cortex, which is not surprising given that regulated exclusion of 
this exon has been shown to terminate on embryonic day 16 in mouse brain10 (termed exon 33). Overall, these 
analyses are consistent with a relatively lower level of RBFOX spicing activity in SCN compared with cerebral 
cortex.
Distinct population of Rbfox2 isoforms in a neuronal cell line. To establish a cellular model for 
the investigation of Rbfox2 isoform function, rat PC12 pheochromocytoma cells were cultured and analysed for 
expression of both endogenous Rbfox2, and known RBFOX2 target genes. RT-PCR with the RBFF6 and RBFR3 
primers used for rat brain analysis produced abundant expression of a product that appeared similar to the PCR 
bands obtained with SCN and cortex RNA (Fig. 1A). However, cloning and sequencing of these cDNAs revealed 
a set of sequences largely distinct form either of the rat brain samples (Supplemental data, SI3). Of 6 sequenced 
clones, one was identical to the original ‘non-variant’ sequence cloned from rat cortex, but the remaining 5 clones 
(−12 × 2; −3b-12; −2–40 + 43 × 2) were distinct from both the SCN and cortex populations, with a notable 
absence of both the −12–40 isoform, and any −93 isoforms in the PC12 population. In contrast, an isoform 
containing a substitution of exon 10 (−40) with a well-established alternative exon 10* (+43)7 was found. This 
result is indicative of the undifferentiated state of the PC12 cells because the alternative (+43) exon is known to 
be absent in brain mRNAs7. However, this clone also contained a novel −2 bp deletion, an apparent micro-exon 
flanked by GT and AG sequences. Overall, the 3 variations in this clone result in a truncated predicted protein 
sequence (Supplemental data, SI3).
Initial analysis of RBFOX target genes in PC12 cells revealed abundant expression of both exon 7-included 
and exon 7-excluded Cacna1c transcripts (Fig. 3C and D), making this exon an ideal target for functional analysis 
of Rbfox2 isoforms.
The SCN-abundant RBFOX2 isoform is functionally impaired. Given that the (−12–40) isoform 
is the most abundant clone in the rat brain sample set, and furthermore distinguishes the SCN and cortex pop-
ulations, a functional analysis of this isoform was conducted using the equivalent (‘non-variant’) isoform for 
comparison. This analysis focused on two aspects of RBFOX function using PC12 cells as an experimental model: 
Sequence variation(nt) Rat Exon Domain Genbank identity SCN clones Cortex clones
None Mm Isoform4 5 2
+32 10 CTD Rno X 18 2 3
−12 + 32 9,10 CTD Rno X 20 1 1
−3a-12 2,3,9 NTD&CTD novel 2
−12–40 9,10 CTD Mm X 27 12 4
−39 9 CTD novel 1
−93 5 RRM novel 5
−93 + 73 5 RRM&CTD Mm Isoform 9 1
−93–12 5/9 RRM novel 2
−93-12-40 5,9,10 RRM&CTD novel 1
−3b-12-40 4,9,10 RRM&CTD novel 2
Total Clones 22 22
Table 1. Summary of Rbfox2 isoform populations in rat brain SCN and cortex. Rbfox2 isoforms are identified 
by sequence variation (eg. + 32 = addition of 32 nucleotide sequence). Note two distinct –3 nt variations (3a 
and 3b). Six isoforms are novel, but others have Genbank annotations. Rno = rat; Mm = mouse. 10 = alternative 
exon 10.
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(i) effect on inclusion of Cacna1c exon 7 (see above), and (ii) effect on gene expression (selecting Egr1 as a docu-
mented example gene)27.
The non-variant Rbfox2 construct was functionally verified in initial transfection experiments that demon-
strated a marked decrease in Cacna1c exon 7 inclusion following 24 h of over-expression (Fig. 3C). In contrast, 
Figure 3. Differential expression of RBFOX-target exons in rat brain cortex (COR) and suprachiasmatic 
nucleus (SCN), and differential activity of RBFOX2 isoforms. (A) Representative agarose gel electrophoresis 
images of RT-PCR analysis using primers directed at transcript regions spanning exons that are documented as 
either included (Grin1 exon 4, Enah exon 12, or excluded (Cacna1c exons 7 & 29) by RBFOX protein activity. 
Exons are numbered according to currently annotated rat gene transcripts (see text). Numbers on right 
indicate amplicon sizes in bp. (B) Schematic representation of gene exon structure. Arrows indicate position 
of proximal (within 500 nt) UGCAUG (consensus RBFOX-binding) sequences. (C) Representative agarose 
gel electrophoresis images of RT-PCR analysis of PC12 cell RNA showing the effect of RBFOX2 (RBF2) over-
expression (vs. emply vector, pc3.1) on exon usage in target genes. Note the marked reduction in Cacna1c 
exon 7 inclusion in the RBF2 lane, but no effect on Cacna1c exon 7. (D) Comparative analysis of non-variant 
RBFOX2 (RBF2) and −12–40 RBFOX2 variant (−12–40) over-expression on Cacna1c exon 7 exclusion in PC12 
cells. Upper: Representative agarose gel electrophoresis images of RT-PCR analysis. Note the Rbfox2 primers 
are specific for exogenous Rbfox2 transcripts. Lower: Quantitative comparison of multiple experiments showing 
a significant reduction of exon 7 inclusion with RBF2 (*p < 0.05 [p < 0.000, 2-tailed] Independent Student’s 
t test) but no significant effect of the −12–40 variant (p > 0.05 [p = 0.743, 2-tailed] Independent Student’s t 
test. Levene’s test for equality of variance: RBF2: F = 6.179, p = 0.047; −12–40: F = 7.762, p = 0.032. Values are 
Mean ± SEM; n = 4 replicate transfections in each group. Note that gel images have been cropped for clarity; 
full-length gel images for each amplicon are shown in Fig. S4.
www.nature.com/scientificreports/
7SCientifiC REPORTS | 7: 9929  | DOI:10.1038/s41598-017-10535-3
no change in expression of Cacna1c exon 29 was observed (Fig. 3C). Interestingly, analysis of Rbfox2 expression 
using primers RBFF4 and RBFR3, that detect both endogenous and exogenous Rbfox2 transcripts, revealed not 
only an anticipated over-expression of Rbfox2, but also (sequence-verified) expression of a (‘−40’; 365 bp) prod-
uct in the Rbfox2-transfected cells, presumably reflecting exclusion of the 40 bp exon 10 from endogenous Rbfox2 
transcripts. Following this verification of functional RBFOX2 activity in the transfection paradigm, additional 
experiments were conducted to quantitatively compare this activity with the −12–40 isoform. Despite similar 
levels of construct expression (verified by amplification of a PCR product derived from the 5′ UTR region of 
pcDNA3.1 coupled with a Rbfox2-specific reverse primer; Fig. 3D), expression of the −12–40 isoform did not 
significantly modify Cacna1c exon 7 inclusion (Fig. 3D).
In contrast to the differential splicing activity of the rat brain Rbfox2 constructs demonstrated above, neither 
construct significantly modified Egr1 mRNA levels in this cellular model. Fold changes in Egr1 mRNA level 
for the different transfections compared to pcDNA3.1 were: ‘non-variant’ Rbfox2, 0.92 ± 0.19, and −12–40, 
1.12 ± 0.17 (n = 4 replicate transfections in each group; ANOVA: F = 0.465 (11), p = 0.642). Actb is also a docu-
mented RBFOX target23 and although not quantitatively analysed here, expression did not appear to be modified 
by rat brain Rbfox2 construct over-expression (Fig. 3C and D).
Discussion
The RBFOX family of RNA binding factors are established regulators of neuronal gene expression4. Individual 
family members are known to be required for aspects of adult brain function28, but, in general, the roles of these 
RBPs in adult brain are largely undefined. In the present study, we have shown that Rbfox2 is expressed in a 
remarkable diversity of isoforms in the adult brain, and also that different brain regions have characteristic iso-
form populations. This analysis has also revealed that RBFOX activity in the RBFOX3/NeuN-depleted SCN, 
appears to be compensated by a change in Rbfox2 isoform population rather than a change in expression levels. 
In the SCN, an abundance of a CTD-variant Rbfox2 isoform (−12–40) is associated with distinct patterns of exon 
utilization in RBFOX target genes. Previous studies have highlighted individual RBFOX isoforms in the brain, for 
example a cytoplasmic variant of RBFOX129, but the diversity of neuronal isoform variation has not previously 
been documented. Our comparative analysis of the cerebral cortex with the SCN has perhaps contrasted two 
extremes, given the unusual, RBFOX3-negative nature of the majority of SCN neurons, and so further analysis is 
required to extend these findings to other neuronal populations in order to identify the extent of variation across 
the brain.
Our study has also demonstrated a functional correlate of the distinct Rbfox2 isoform populations, in that 
the SCN-enriched CTD-variant Rbfox2 isoform lacks the functional activity of an equivalent non-variant iso-
form. As a consequence, the relative loss of RBFOX2-mediated exon exclusion from a L-type calcium channel 
gene, Cacna1c, may underlie the presence of this exon within SCN Cacna1c transcripts. These findings have 
additional relevance to this study because inclusion of this exon is known to be developmentally down-regulated 
in brain cortex10, providing further evidence of an immature molecular phenotype in the SCN14, 19. Our control 
experiments have confirmed RBFOX2-mediated exclusion Cacna1c exon 7, as originally demonstrated by Tang 
and colleagues10, and provide an interesting in vivo context for this activity because these authors showed that 
the Cacna1c exon responds to relatively small changes in RBFOX2 levels. Hence, differences in the relative pro-
portions of Rbfox2 isoforms between SCN (eg. −12–40, >50%) and cortex (<20%) are likely to be functionally 
relevant.
The major importance of alternative splice regulation in neurons lies in the generation of protein isoforms 
with altered properties; variant ion channels, for example, which affect neurophysiological output, and therefore 
information processing30. Inclusion of Cacna1c exon 7 has been shown to modify the electrophysiological prop-
erties of the Cacna1c-encoded CaV1.2 channels10. Regulated splicing of the CaV1.2 channel is interesting in the 
context of this study because CaV1.2 is involved in resetting of the circadian clock within the SCN31. However, the 
Cacna1c gene is subject to extensive splice variation, and the physiological significance of much of this variation 
remains undefined32.
We have also provided evidence of other RBFOX-targeted gene exons, Grin1 exon 45 and Enah exon 127, 26 that 
are differentially expressed in the SCN, also reflecting an apparent relative loss of RBFOX activity. For the NMDA 
receptor subunit gene Grin1, we have confirmed an absence of the variable exon 4 in SCN mRNAs16, 17 and, con-
versely, clear exon 4 expression in cerebral cortex33, 34. Inclusion of Grin1 exon 4 is directly mediated by RBFOX 
proteins, presumably via a cluster of binding sites downstream of exon 45. For the Enah gene, not previously been 
studied in the SCN, we show for the first time that exon 12, a known RBFOX-regulated exon26 is included in cor-
tical transcripts, but not in SCN transcripts.
Exons in the Cacna1c, Grin1 and Enah genes are experimentally verified RBFOX2 targets as established in an 
extensive HITS-CLIP analysis of individual RBFOX proteins23. In the latter study, genome-wide RBFOX exon tar-
gets are ranked according to FDR score: Rbfox2 (+93) is ranked 9, Grin1 (exon5) ranked 4, and Cacna1c (exon 9) 
ranked 554. Also, in this study, the potassium channel gene Kcma1 is identified as a major target of RBFOX with 
exons ranked in positions 198, 376 and 669. We have not studied the Kcnma1 in the current study but previous 
work has identified that the ‘STREX’ splicing site18 lacks inserts in the SCN, again consistent with relative loss of 
RBFOX activity in these neurons due to prediction of exon inclusion in the HITS-CLIP analysis18.
The generation of Rbfox2 isoforms observed in the current study may be multifactorial, involving different 
RBPs, and other molecular mechanisms. However, given the extensive evidence of Rbfox autoregulation35, it is 
likely that differential isoform generation is at least partly RBFOX-regulated. For example, the abundance of the 
−93 isoform in cortex relative to SCN would be consistent with RBFOX3/NeuN enhanced skipping of RRM exons 
that generate this dominant negative isoform25, 36. In contrast, the relative absence of RBFOX3/NeuN in the SCN 
removes this influence on Rbfox2 isoform generation25, resulting in a distinct population of neuronal isoforms. 
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Our analysis of genomic sequence around regulated Rbfox2 exons has identified potential target sequences that 
are proximally positioned to mediate auto-regulation. This analysis is supported by recent genome-wide analyses 
of RBFOX target sites7, 23 that identify the ‘40’ and ‘93’ exons as targets. Many RBFOX consensus sites are located 
distally (>500 nt) from exons, but it should be noted that RNA bridges can mediate distal regulation37.
Our major finding of a multiplicity of Rbfox2 isoforms in the adult brain raises the question of protein func-
tion associated with these individual variations. Our sequence evidence implies that these variants are translated 
because most sequence variations are integrated with alternative stop codon usage that maintains an open reading 
frame. Previous evidence also shows that alternative Rbfox transcripts are associated with translated proteins 
and not simply subject to NMD5. Consequently, it is possible to generate many different proteins with different 
functional properties, relating to one or more aspects of RNA binding, protein interaction and cellular (nuclear/
cytoplasmic) localization. Previous studies have identified RBFOX2 isoforms with dominant negative activity, for 
example the −93 isoform can act as a dominant negative because the RRM is partially deleted leading to reduced 
RNA binding but maintained association with other splicing factors36. Our results may indicate a requirement 
for such activity in cortical neurons where these isoforms are more abundant. The relatively lower level of these 
isoforms in SCN would be consistent with a need to compensate for the loss of RBFOX3/NeuN in these neurons. 
However, our current analysis of Rbfox2 expression in the SCN is generally consistent with a relative loss of 
RBFOX activity that appears to be appropriate for the required splicing patterns in functional SCN genes.
The SCN is characterized by an abundance of the −12–40 isoform that codes for a CTD-variant isoform. 
Alternative usage of the 40 bp exon 10 in mouse brain and muscle has been documented previously38, but the 
40 nt exon 10 was substituted with a 43 nt exon rather than deleted. In the rat brain areas analysed here, we have 
found that deletion of the 40 bp exon 10 is exclusively associated with an additional, novel deletion of an upstream 
12 bp sequence. The resultant amino acid changes in the CTD are significant, involving loss of alanines, (33 A’s 
in the ‘non-variant’ protein compared with 16 in −12–40, and loss of a ATATAATAAAAAAAAY sequence) and 
addition of glutamine (+5) and proline (+11) residues, resulting in five closely-spaced QP dimers. These changes 
may be crucial for splicing function because the CTD is required for RBFOX2 splicing activity39–42, acting, at 
least partly, to mediate protein interactions12, 41. CTD variation may relate to the recently demonstrated, but 
unexplained selection of distinct RBFOX binding sites by RBFOX28. Alternatively, the variant CTD may confer 
other, non-splicing, functions related to mRNA processing (see below), possibly explaining the enrichment of 
glutamines43 and QP repeats44.
Although much of the work on RBFOX proteins has necessarily focused on their role in splicing, recent 
work has provided evidence for other regulatory roles. Both RBFOX145 and RBFOX246, 47 can modify mRNA 
levels in the cytoplasm via actions at the 3′ UTR. In the adult rat brain including the SCN, we found no evi-
dence of cytoplasmic RBFOX2. However, other recent work has shown that RBFOX2 can have a more general 
role in gene regulation, acting (largely) as a transcriptional repressor in conjunction with polycomb complex 2 
(PRC2)27. The RBFOX2 protein domain interacting with PRC2 is the CTD, shown here to be significantly mod-
ified in the SCN-abundant −12–40 isoform. A consequent change in gene repression in the SCN may therefore 
explain some of the unusual patterns of gene expression in SCN neurons14, 19. In the current study, one of the 
RBFOX2-suppressed genes, Egr127, was measured in an RBFOX2 over-expression paradigm, but no consistent 
changes in Egr1 expression were observed. Further studies, possibly in other cellular contexts27, are required to 
confirm these regulatory actions of RBFOX2.
In conclusion, our demonstration of distinct populations of Rbfox2 variants in the adult brain is consistent 
with our widening knowledge of neuronal transcript diversity, as demonstrated in current single-cell sequencing 
projects48. Our additional finding of further (novel) variants in PC12 cells is suggestive of a multiplicity of Rbfox2 
transcript populations that may be a defining feature of individual cell types. In the SCN, where RBFOX3/NeuN 
is largely absent, our finding that there are similar levels of Rbfox2 transcripts and protein but distinct isoform 
populations is indicative of a novel cellular strategy for directing cell-specific RBFOX activity. Further studies are 
required to understand how the changes in Rbfox expression may relate to specific SCN function; for example, 
‘immature’ aspects of SCN physiology49, or possibly the requirement for daily cycles of regulated splicing18, 50, 51. 
These studies must take into account other RBPs such as NOVA, which can act synergistically with RBFOX 
proteins to regulate neuronal gene splicing52, and also activity of RBFOX1. At a more general level, the current 
insights into brain Rbfox2 gene expression may have clinical relevance because the RBFOX-regulatory network is 
associated with autism, and RBFOX-target genes, including Cacna1c, are recognized autism susceptibility genes23.
Methods
Animals. Sprague-Dawley male rats were used in accordance with both the UK Animals (Scientific 
Procedures) 1986 Act of Parliament, and Cardiff University ethical review. All experimental protocols were 
approved by, and conducted under, UK Home Office licencing. The health status of the animals was monitored by 
a veterinarian. Rats were maintained in standard laboratory conditions (14:10 light:dark cycle, lights on: 05.00 h) 
with ad libitum access to rodent food and drinking water, and sampled at 17.00 h. For immunohistochemical 
analysis of postnatal day 50 (PND50) brain, animals were terminally anaesthetized with sodium pentobarbitone 
(150 mg/kg, i.p), and perfused via the ascending aorta with phosphate buffered saline (PBS), followed by 4% 
paraformaldehyde in 0.1 M phosphate buffer (PFA). Dissected brains were then post-fixed (PFA, overnight, 4 °C). 
Alternatively, for PND10 rats killed by a Schedule 1 method, brains were rapidly dissected prior to fixation in 
4% PFA (24 h, 4 °C). Both PND50 and PND10 brains were then cryoprotected (20% sucrose in 0.1 M phosphate 
buffer; PND50: overnight, 4 °C; PN10: 24 h, 4 °C), and stored briefly at –80 °C prior to sectioning. For RT-PCR 
analysis of PND50 brain, rats were killed by a Schedule 1 method, and discrete punches of SCN and cerebral 
cortex (parietal) tissue were sampled using a method53 optimized by the use of a rat brain matrix (RBMA-300C, 
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World Precision Instruments Inc., Sarasota, FL, USA) and blunted 15 G needles. Tissue from 3 rats was pooled in 
each sample used for RT-PCR.
Immunohistochemistry. Coronal sections of rat brain (12 µm; bregma 0.0 mm to −2.0 mm)54 were pre-
pared using a cryostat (Leica CM1900; Leica Imaging Solutions Ltd., Cambridge, UK), and mounted on glass 
slides (SuperFrost Plus, VWR International Ltd., East Grinstead, West Sussex, UK). Following brief drying, slides 
were stored at −80 °C prior to analysis. Sections containing the SCN were selected, and protein expression was 
analysed using fluorescence immunohistochemistry55. The primary antibodies used for immunohistochemis-
try (RBFOX2, RBM9 IHC-00199, Bethyl Laboratories Inc., Montgomery, TX, USA; NeuN/RBFOX3, MAB377, 
Millipore, Temecula, CA, USA), and MeCP2 (4B4, Active Motif, Carlsbad, CA, USA), have been used in our pre-
vious studies19, 55, 56, and have been validated both positively (excitation light-specific detection), and negatively 
(absence of detection when the primary antibody is omitted). The epitope recognized by IHC-00199 maps to a 
region in the N-terminal domain (residues 1–50 of hRBFOX2; NP_055124.1) that is 100% conserved between 
human and rat. Note that this antibody will not distinguish RRM and CTD variants of RBFOX2. The second-
ary antisera used were: Cy3-conjugated sheep anti-rabbit IgG (Sigma Aldrich, Dorset, UK), and Alexa Fluor 
488-conjugated donkey anti-mouse IgG, (Molecular Probes Inc, Eugene, OR, USA). Following washing, sections 
were mounted in Vectashield with DAPI (Vector Laboratories, Burlingame, CA, USA), stored at 4 °C, and then 
viewed with a fluorescence microscope (Leica DM-LB, Leica). Representative images were photographed with a 
Leica DFC-300FX digital camera linked to Leica QWin software (V3), and assembled in Photoshop (CS2, Adobe 
Systems Inc., San Jose, CA, USA). Expression of RBFOX2 in the SCN was confirmed in at least 6 brain sections 
from 2 rats.
RT-PCR analysis of rat brain mRNAs. Total cellular RNA was extracted from rat brain samples using 
Trizol (Invitrogen protocol, Thermo Fisher Scientific, Waltham, MA, USA) and DNaseI-purified (Promega pro-
tocol; Promega, Madison, WI, USA). cDNA was generated with the Superscript II protocol (Life Technologies, 
Thermo Fisher Scientific) using an Oligo (dT) primer. PCR was conducted using standard procedures with 
either REDTaq ReadyMix (Sigma, Aldridge, St.Louis, MO, USA), or Q5 Hot-Start High-Fidelity DNA polymer-
ase (NEB, Ipswich, MA, USA). Oligonucleotides used for amplification are listed in Table S1. Amplified prod-
ucts were visualized after agarose gel electrophoresis, with reference to a DNA ladder (Hyperladder I, Bioline, 
London, UK or 1 kb ladder, Promega), using GeneSnap (Syngene, Frederick, MD, USA), and relative levels of 
PCR bands measured using Image J57. For cloning and sequence analysis, PCR products were purified (Qiaex II 
gel extraction kit, Qiagen, Hilden, Germany) and either directly ligated into pGEM-T (Promega protocol), or, in 
the case of Q5-amplified products, ‘A-tailed’ (Promega protocol) prior to ligation. Ligations were transformed 
into JM109 cells (Promega), and transformants were selected for plasmid purification (Wizard SV Miniprep pro-
tocol, Promega). PCR products were then sequenced (Eurofins MWG Operon, Ebersberg, Germany).
For the analysis of Rbfox2 isoform distribution within different brain areas, a total of 44 clones were sequenced 
(22 SCN comprising 10, 6 and 6 clones from SCN sample pools (3 rats in each pool) A, B & C respectively; 22 cor-
tex comprising 10, 6 and 6 clones from Cortex sample pools (3 rats in each pool) A, B & C respectively). For the 
analysis of RBFOX splicing targets in SCN and cortex, exon exclusion/inclusion was verified in at least two inde-
pendent PCR reactions using independent brain samples from the same sample pools used for Rbfox2 isoform 
analysis. A quantitative analysis of Cacna1c exon 7 inclusion in SCN and cortex was conducted by measuring the 
relative levels of exon 7 included, and excluded products (see Results).
Quantitative RT-PCR analysis. For the quantitative analysis of Egr1 mRNA levels, real-time PCR analysis 
was performed with the qPCRBIO SyGreen Mix (PCR Biosystems protocol, PCR Biosystems Ltd, London, UK) 
on a Mx3000P machine (Agilent, Santa Clara, CA, USA) using the 2−ΔΔCT method for quantitation. For this anal-
ysis, reverse transcription reactions (see above) were conducted using a mixture of oligo (dT) and an 18S-specific 
primer in order that 18S RNA (template diluted 1/1000 for QPCR) could be used for reference58. This approach 
for normalization was adopted due to the reported widespread effects of RBFOX2 across the transcriptome27.
Expression of Rbfox2 isoforms in cell culture. PC12 cells (Gift of Prof. D. Murphy, University of 
Bristol, UK) were grown in DMEM with 10% horse serum, 5% Fetal Bovine Serum and 1x antibiotic/antimycotic 
(Invitrogen) at 37 °C and 5% CO2. For experimental analysis, cells (1 × 105/well of a 12-well plate;) were trans-
fected (TransFast protocol, Promega) with Rbfox2 constructs (250 ng, PureYield plasmid, Promega protocol) and 
maintained for 24 h prior to RNA extraction using Trizol (Invitrogen protocol). RNA samples were reverse tran-
scribed as described above and transcripts were analysed using end-point PCR (REDTaq Readymix) with cycle 
numbers appropriate for individual transcripts (range: 28–34 cycles). Following agarose gel electrophoresis, gel 
images were captured (GeneSnap, Syngene) and relative levels of PCR bands measured using Image J57. Rbfox2 
expression constructs were based on isoform sequences obtained in the analysis of rat brain transcripts. Selected 
Rbfox2 sequences were re-amplified using primers containing 5′ HindIII or BamHI sites, sequence-verified, and 
then ligated into the MCS of pcDNA3.1(+). In order to optimize expression of RBFOX2 protein, the 5′ UTR was 
modified with a single (non-coding) base change to generate a consensus Kozak sequence. For the analysis of 
endogenous PC12 Rbfox2 transcripts, PC12 cells were similarly plated and maintained in the absence of transfec-
tion. Following RNA extraction, PC12 Rbfox2 transcripts were cloned and sequenced as described above (total 
of 6 Rbfox2 clones).
Bioinformatics and statistical analysis. Genomic and transcript analysis was performed using the 
UCSC and Ensembl Genome Browsers (genome.ucsc.edu; ensembl.org). Sequence identity was initially con-
firmed using BLAST (blast.ncbi.nlm.nih.gov), and sequence comparisons were conducted with Clustal Omega 
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(ebi.ac.uk/Tools/msa/clustalo). Nuclear localization signals were identified using CNLS MAPPER (nls-mapper.
iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi). Statistical analysis was conducted with IBM SPSS Statistics ver-
sion 20 (IBM, New York, USA) by applying different tests as indicated in Results, and Levene’s test for equality of 
variance. The requirement to use multiple end-point PCR reactions for comparative analysis of endogenous splice 
variation across single exons necessarily compromises inter-assay variation, and therefore independent Student’s 
t-tests were used to compare the activity of the two expression constructs with control transfections.
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